根据个体情况调整临床目标是个好主意，脑科学的经验教训能有所帮助。
Tailoring clinical goals to the individual is a good idea, and lessons from brain science can help.
作者信息
Damme Katherine S F, Mittal Vijay A
机构信息
University of Texas-Dallas, School of Brain and Behavioral Sciences, Department of Psychology.
Northwestern University, Department of Psychology.
出版信息
J Psychopathol Clin Sci. 2025 May;134(4):345-347. doi: 10.1037/abn0000979.
Zilcha-Mano (see record 2026-05243-001) provided several important insights relating to our recent special issue on utilizing data from brain science to better manage clinical heterogeneity (Damme & Mittal, 2024) and expanded on these ideas by emphasizing that individualized definitions of what "healthy" is an important consideration as well. We agree that tailoring treatment planning to an individual person is a very good idea, and, in a related point, we have recently argued that efforts to manage clinical heterogeneity are only as good as the quality of the outcome variables in consideration (see Kraus et al., 2024). In this commentary, we discuss potential barriers, caveats, and considerations and suggest theoretical intersections where lessons from brain research may help. (PsycInfo Database Record (c) 2025 APA, all rights reserved).
齐尔查-马诺（见记录2026-05243-001）提供了一些重要见解，与我们最近关于利用脑科学数据更好地管理临床异质性的特刊相关（达姆 & 米塔尔，2024年），并通过强调对“健康”的个体化定义也是一个重要考虑因素，对这些观点进行了扩展。我们同意根据个人情况定制治疗方案是个非常好的想法，并且，与此相关的是，我们最近认为管理临床异质性的努力仅与所考虑的结果变量的质量一样好（见克劳斯等人，2024年）。在这篇评论中，我们讨论了潜在的障碍、注意事项和考虑因素，并提出了脑研究的经验教训可能有所帮助的理论交叉点。（PsycInfo数据库记录（c）2025美国心理学会，保留所有权利）
Zotero 插件